Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

This bill requires health insurance plans in New Jersey to cover oral anticancer medications on terms no less favorable than intravenous anticancer medications. It specifically prohibits patients from being charged additional upfront costs beyond standard copayments, deductibles, or coinsurance for oral anticancer medications. The policy applies to various health benefit plans including individual, group, employer-sponsored, and state health benefit programs. It directly affects cancer patients who previously faced significant out-of-pocket expenses before receiving reimbursement for oral cancer medications. The law prevents insurers from increasing patient cost sharing to comply with the coverage requirements.